Norrie disease is a rare, inherited genetic disorder that primarily affects the development of the eyes and ears. It is characterized by congenital blindness, meaning affected individuals are born blind or lose their vision shortly after birth. The condition is caused by mutations in the NDP gene, which provides instructions for making a protein called norrin. This protein is crucial for the normal development of blood vessels in the retina (the light-sensitive tissue at the back of the eye) and the inner ear.
The most prominent sign of Norrie disease is leukocoria, a condition where the pupils appear white when light is shone on them. This occurs because masses of immature retinal cells accumulate at the back of the eye. Over the first few months of life, the irises or the entire eyeballs may shrink and deteriorate, and cataracts may eventually develop. Because the retinal blood vessels do not form correctly, the retina can detach, leading to profound and irreversible vision loss.
In addition to vision loss, about 30 percent of individuals with Norrie disease develop progressive sensorineural hearing loss. This type of hearing loss originates in the inner ear or the auditory nerve and often begins in early childhood, worsening over time. The combination of early blindness and progressive hearing loss presents significant challenges for affected individuals and their families.
Beyond sensory impairments, Norrie disease can also affect other body systems. Approximately 30 to 50 percent of people with the condition experience developmental delays, particularly in motor skills such as sitting up and walking. Mild to moderate intellectual disabilities, behavioral issues (such as autism-like symptoms or pseudobulbar affect, which causes uncontrollable laughing or crying), and peripheral vascular disease (problems with blood circulation in the limbs) may also occur.
Diagnosing Norrie disease typically involves a thorough clinical evaluation, including a detailed eye examination by an ophthalmologist. Genetic testing can confirm the diagnosis by identifying mutations in the NDP gene. While there is currently no cure for Norrie disease, early diagnosis is essential for managing symptoms and providing appropriate support. Multidisciplinary care involving ophthalmologists, audiologists, pediatricians, and developmental specialists is crucial to optimize the quality of life for individuals living with this condition. Patients and families should consult their healthcare provider for personalized medical advice and management strategies.